Chronic Lymphocytic Leukemia (CLL) and White Blood Cell Count
Diagnostic Criteria and WBC Elevation
- The diagnosis of CLL is established by a sustained increase of peripheral blood lymphocytes ≥ 5 × 10^9/L (5,000/μL) not explained by other clinical disorders 2, 3
- CLL is characterized by the predominance of small, morphologically mature lymphocytes in the blood smear 2
- The composite immunophenotype of these cells is typically CD5+, CD19+, CD20+ (low), CD23+, sIg low, CD79b low, FMC7– which distinguishes CLL from other CD5+ B-cell lymphomas 2
Degree of WBC Elevation in CLL
- Unlike in acute leukemias, even markedly elevated WBC counts in CLL (hyperleukocytosis) rarely cause symptoms related to leukocyte aggregates 3, 4
- The absolute lymphocyte count should not be used as the sole indicator for treatment, despite sometimes reaching very high levels 3, 5
Clinical Significance of WBC Elevation
- Treatment decisions should be based on disease-related symptoms and progressive disease rather than absolute lymphocyte count alone 3, 4
Indications for Treatment Related to WBC Count
- Progressive lymphocytosis with an increase of more than 50% over a 2-month period or lymphocyte doubling time (LDT) of less than 6 months may be an indication for treatment 3
- Factors contributing to lymphocytosis other than CLL (e.g., infections) should be excluded before initiating treatment 3
Monitoring WBC in CLL
- For patients not requiring treatment (watch and wait approach), blood cell counts should be monitored every 3-6 months 1, 2
- For patients on treatment, complete blood counts with differential should be performed regularly to assess response 3, 4
- A complete remission requires peripheral blood lymphocytes below 4 × 10^9/L (4,000/μL) after completion of therapy 4